Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Kathryn Teng, MD, FACP is Director of the Center for Personalized Healthcare and will lead the new center and its efforts to incorporate personalized healthcare approaches and tailored care plans across all facets of patient care within Cleveland Clinic. She is a Staff Physician in the Medicine Institute at Cleveland Clinic. Dr. Teng is also an Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western University.
Dr. Teng joined Cleveland Clinic in 2007 following a faculty appointment at Harvard Medical School and Massachusetts General Hospital. She completed her internship in Obstetrics and Gynecology at Vanderbilt University Medical Center, and she completed her internship and residency in Internal Medicine at Vanderbilt University Medical Center. Dr. Teng is board-certified in Internal Medicine.
Dr. Teng specializes in comprehensive and preventive care for adult patients. She has committed her career to advocacy for her patients and education of medical students. Her areas of clinical interest include primary care women’s health and office gynecology. In addition, she is involved in medical and graduate education and has served as the Director of General Internal Medicine Grand Rounds from 2007-2010. Dr. Teng is an active member of the American College of Physicians and has participated in efforts towards patient advocacy, access to care and healthcare reform. She has served as the Patient Experience Officer for the Medicine Institute of Cleveland Clinic from 2008-2010 and created the first Voice of the Patient Advisory Council for the Medicine Institute. She is committed to efforts such as Personalized healthcare, efforts which promise to shape the future practice of medicine and improve the value of healthcare for patients.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/25/2013, Dr. Teng has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.